BOSTON (AP) — BOSTON (AP) — Pieris Pharmaceuticals Inc. (PIRS) on Wednesday reported a loss of $13.2 million in its first quarter.
The Boston-based company said it had a loss of 18 cents per share.
The biopharmaceutical company posted revenue of $1.9 million in the period.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PIRS at https://www.zacks.com/ap/PIRS
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.